Researchers developed a method to dissect immune-regulatory programs via integrative time-series analysis and high-content CRISPR screening.

Researchers plan to collaborate on preclinical trials to apply polymersomes to real-world vaccine or drug delivery challenges.

A new vaccine design pipeline could protect against emerging SARS-CoV-2 variants and pinpoint conserved T-cell epitopes across respiratory viruses.